Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TransPacific Venture Capital Partners is a venture capital firm established in approximately 2018, headquartered in San Francisco, California, with an additional office in Sydney, Australia. The firm specializes in investing in innovative healthcare companies that aim to improve health outcomes and enhance quality of life across the Pacific Rim. TransPacific VC focuses on sectors such as biopharmaceuticals, medical technologies, and digital health, targeting companies that are at the forefront of these industries.
The firm has built a portfolio of 12 companies, emphasizing late-stage clinical development and novel therapeutics, particularly in major disease areas like oncology and Alzheimer's disease. TransPacific VC leverages its extensive network of healthcare executives and practitioners to provide strategic guidance and operational support to its portfolio companies. This approach helps enhance the growth and success of their investments.
TransPacific Venture Capital Partners primarily invests in the healthcare sector, with a strong emphasis on biopharmaceuticals, medical technologies, and digital health. The firm targets late-stage clinical development companies, particularly those working on novel therapeutics in significant disease areas such as oncology and Alzheimer's disease. Additionally, TransPacific VC is interested in advancements in healthcare delivery systems, especially those that utilize artificial intelligence to improve patient outcomes.
The firm seeks to identify and support companies that are innovating within these sectors, focusing on those that demonstrate potential for significant impact on health outcomes. TransPacific VC's investment strategy is characterized by a preference for later-stage investments, including Series A, B, and C rounds, as well as growth equity opportunities. This focus allows the firm to engage with companies that are already established and have a clear path toward commercialization.
TransPacific Venture Capital Partners has a diverse portfolio of 12 notable companies, primarily in the healthcare sector. The following companies are included:
This portfolio reflects TransPacific VC's commitment to investing in companies that are making significant advancements in healthcare, particularly in oncology and neuroscience.
To pitch TransPacific VC, founders should send an email to info@transpacificvc.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. The firm prefers detailed presentations that highlight the company's potential impact on healthcare outcomes.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
What are TransPacific VC's investment criteria?
TransPacific VC primarily invests in healthcare companies, focusing on biopharmaceuticals, medical technologies, and digital health. The firm targets late-stage clinical development and novel therapeutics, particularly in oncology and Alzheimer's disease.
How can I pitch to TransPacific VC?
Founders can reach out to TransPacific VC via email at info@transpacificvc.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes TransPacific VC different from other investors?
TransPacific VC differentiates itself through its extensive network of healthcare executives and practitioners, providing strategic guidance and operational support to its portfolio companies. This deep industry expertise enhances the growth potential of their investments.
What is the geographic focus of TransPacific VC?
The firm invests across the Pacific Rim, with a particular focus on North America, Asia, and Oceania. This geographic diversity allows them to tap into various healthcare markets and innovations.
What stages does TransPacific VC invest in?
TransPacific VC invests in Series A, Series B, Series C, and growth equity rounds, focusing on companies that are already established and have a clear path toward commercialization.
What type of support does TransPacific VC provide to portfolio companies?
The firm offers operational support, strategic guidance, and access to key resources through its network of healthcare professionals, which can significantly enhance the success of its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.